The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...

Becoming the first treatment for rare genetic disorder Prader-Willi syndrome, breakthrough therapy drug DCCR (diazoxide choline) gained U.S. FDA approval as Vykat XR the evening before its March 27 ...

Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi ...

Soleno Therapeutics has won US Food and Drug Administration (FDA) approval for diazoxide choline – which will be branded as ...

The dosage for Abilify (aripiprazole) may depend on the condition being treated and the form of the drug prescribed ... Maintena comes in two strengths: 300 mg and 400 mg. Abilify Asimtufii ...

After four days, Mobile World Congress has come to an end. During our time in Barcelona, we saw countless phones, wearables, AI implementations and gadgets on display.

Note: Rybelsus tablets come in two formulations, which are not interchangeable. For example, one 3-mg tablet of Rybelsus formulation R1 is not equivalent to two 1.5-mg tablets of formulation R2.

There’s a ton of buzz behind Samsung’s upcoming XR headset, but the South Korean tech giant isn’t stopping there. The company is also working on a pair of glasses. If details on the headset ...